BA
ELV icon

Boston Advisors’s Elevance Health ELV Stock Holding History

Boston Advisors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-785
Closed -$222K – 607
2019
Q2 		$222K Sell
785
-7,968
-91% -$2.18M 0.01% 612
2019
Q1 		$2.51M Buy
+8,753
New +$2.53M 0.13% 198
2016
Q2 		– Sell
-7,279
Closed -$1.01M – 680
2016
Q1 		$1.01M Sell
7,279
-359
-5% -$48K 0.02% 328
2015
Q4 		$1.06M Sell
7,638
-146,891
-95% -$20.2M 0.02% 324
2015
Q3 		$21.6M Sell
154,529
-8,695
-5% -$1.31M 0.81% 16
2015
Q2 		$26.8M Sell
163,224
-19,642
-11% -$3.14M 1.12% 12
2015
Q1 		$28.2M Buy
182,866
+7,556
+4% +$1.08M 1.12% 12
2014
Q4 		$22M Buy
175,310
+3,663
+2% +$453K 0.93% 23
2014
Q3 		$20.5M Buy
171,647
+53,920
+46% +$6.18M 0.87% 30
2014
Q2 		$12.7M Buy
117,727
+1,088
+0.9% +$112K 0.54% 57
2014
Q1 		$11.6M Buy
116,639
+424
+0.4% +$38.3K 0.52% 64
2013
Q4 		$10.7M Buy
116,215
+567
+0.5% +$50.4K 0.51% 65
2013
Q3 		$9.67M Sell
115,648
-35,357
-23% -$3.03M 0.51% 65
2013
Q2 		$12.4M Buy
+151,005
New +$11.3M 0.59% 57

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
TCI Fund Management
TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return

Boston Advisors's ELV Position: Q3 2019 in Review

Boston Advisors sold out of Elevance Health (ELV) in Q3 2019, closing a stake of 785 shares — an estimated $222K sold.

Boston Advisors first reported a position in ELV in Q2 2013 and held it in 14 quarters. The position peaked at $28.2M in Q1 2015. 1,014 funds tracked by Wall St. Rank hold ELV as of Q3 2019.

  • Boston Advisors reported no remaining Elevance Health position as of Q3 2019 after selling out during the quarter.
  • Boston Advisors sold 785 Elevance Health shares in Q3 2019, an estimated $222K.
  • Boston Advisors first reported a position in Elevance Health in Q2 2013 and held it in 14 quarters.
  • Boston Advisors's Elevance Health position peaked at $28.2M in Q1 2015.
  • 1,014 funds tracked by Wall St. Rank held Elevance Health as of Q3 2019.

Based on Boston Advisors's 13F filing for Q3 2019, filed 5 Nov 2019.